2024 SCOPE Summit Insights: Navigating New Clinical Trial Change
The 2024 SCOPE Summit catalyzed thought-provoking dialogue on the transformative currents sweeping through the clinical trials landscape. Hassan Kadhim,...
Clinical Research
eCOA: Should Sponsors Give Clinical Sites More Control?
Electronic Clinical Outcome Assessments (eCOA) have significantly advanced clinical trials, offering a more accurate and efficient data collection method....
How to Avoid The Dangers of Duplicate Participants in Clinical Trials
The prevalence of duplicate participants in clinical trials poses significant risks, compromising the integrity of data and the safety...
How Practical Is FDA’s HCP Approach in DCTs?
The FDA’s latest guidance on Decentralized Clinical Trials (DCTs) marks a pivotal shift in the clinical research landscape. This...
Latest Clinical Trial Tech Emerges: A Medidata NEXT Insight
At the 2023 Medidata NEXT conference, prominent figures like Michelle Hartman from South Broward Research, Adam Kinsey from Merck,...
Revolutionary Digital Twins: The Future of Clinical Trials
In this interview with Gian Carlo (GC) Ochoa, a leading figure in digital twins technology for clinical trials, we...
Cytonics CYT-108: A Unique Approach to OA Treatment
In this interview, we spoke with Joey Bose, President & CEO of Cytonics, diving into the intricacies of their...
A Great Divide: Sponsors Clash With FDA on Trial Data Excess
A new study, conducted collaboratively by the Tufts Center for the Study of Drug Development (Tufts CSDD), the FDA,...
Clinical Trial GCP Focus: Powerful QA Strategies Revealed
One of the most well-received presentations from Momentum Events’ December 2023 2nd GCP Inspection Readiness Conference was Tony Johnson,...
FDA Unveils Groundbreaking Rare Disease Guidance Document
In a landmark move, the U.S. Food and Drug Administration (FDA) has released a detailed guidance document titled “Rare...